← Back to Search

Hyaluronic Acid Derivative

HYMOVIS for Osteoarthritis

N/A
Waitlist Available
Research Sponsored by Fidia Farmaceutici s.p.a.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Symptomatic osteoarthritis of the knee.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 26 weeks
Awards & highlights

Study Summary

The purpose of this study is to determine whether intra-articular hyaluronic acid provides symptomatic relief of osteoarthritis of the knee.

Eligible Conditions
  • Osteoarthritis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~26 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 26 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Pain Sub-score
Secondary outcome measures
Patient Global Assessment

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: HYMOVISExperimental Treatment1 Intervention
HYADD(TM) 4 Hydrogel Intra-Articular Injection
Group II: PlaceboPlacebo Group1 Intervention
Saline Intra-Articular Injection
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HYMOVIS
2015
N/A
~50

Find a Location

Who is running the clinical trial?

Fidia Farmaceutici s.p.a.Lead Sponsor
32 Previous Clinical Trials
4,160 Total Patients Enrolled
5 Trials studying Osteoarthritis
1,184 Patients Enrolled for Osteoarthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee
2014. "Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02187549.
All > Arthritis > Oa
~31 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top